Stay updated on Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A site-wide notice announces a transition in NIH content from the term “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:28:27.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2; the page remains a 403 Forbidden error page.
    Difference
    0.2%
    Check dated 2026-10-18T20:34:53.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T20:35:08.000Z thumbnail image
  4. Check
    37 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, indicating the study record is inaccessible. This change replaces the expected study content with the standard error view and related header/footer.
    Difference
    20%
    Check dated 2026-09-20T20:49:36.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    Revision banner updated to v3.6.6, replacing v3.6.5. This reflects a page version update without changes to the study content or results.
    Difference
    0.1%
    Check dated 2026-08-30T17:13:49.000Z thumbnail image
  6. Check
    80 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This reflects an update to the page version.
    Difference
    0.1%
    Check dated 2026-08-09T09:14:37.000Z thumbnail image

Stay in the know with updates to Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Relatlimab in MSS Colorectal Cancer Clinical Trial page.